Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus

Rheumatology International

Volumn 32, Issue 6, 2012, Pages 1727-1731

  Lian, Fan ^a   Chen, Dongying ^a   Wang, Yu ^a   Ye, Yujin ^a   Wang, Xiaodong ^b   Zhan, Zhongping ^a   Xu, Hanshi ^a   Liang, Liuqin ^a   Yang, Xiuyan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Logistic regression; Predictor; Pulmonary arterial hypertension; Systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DOPPLER ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART CATHETERIZATION; HUMAN; INFLAMMATION; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; LUNG ARTERY PRESSURE; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; CHINA; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84863863117     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1880-4     Document Type: Article

References (32)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G et al (2004) Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(Suppl S):5S-12S
2. Tanoue LT (2003) Pulmonary hypertension in the collagen vascular diseases. Semin Respir Crit Care Med 24:287-296
3. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V et al (2006) Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173:1023-1030
4. Li EK, Tam LS (1999) Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 26:1923-1929
5. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM et al (1987) Primary pulmonary hypertension. A national propective study. Ann Intern Med 107(2):216-223
6. Koh ET, Lee P, Gladman DD, Abu-Shakra M (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35:989-993
7. Quismorio FP Jr, Sharma O, Koss M, Boylen T, Edmiston AW, Thrnton PJ et al (1984) Immunopathologic, clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 13(4):349-359
8. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch D, et al (2010) Characterization of connective tissue disease associated pulmonary arteraial hypertension from the reveal registry: identifying system sclerosis as a unique phenotype. Chest 138(6):1383-1394
9. Jais X, Launay D, Yaici A, Le Pavec J, Tcherakian C, Sitbon O et al (2008) Immunosuppressive therapy in lupus-and mixed connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum 58(2):521-531
10. Hochberg MC (1997) For the diagnostic and therapeutic criteria committee of the American college of rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
11. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM et al (1987) Primary pulmonary hypertension, A national prospective study. Ann Intern Med 107:216-233
12. Galie N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European society of cardiology. Eur Heart J 25(24):2243-2278
13. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H et al (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(Suppl S):40S-47S
14. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M (2006) Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130:182-189
15. Hachulla E, Gresin V, Guillevin L, Carpentier P, Diot E, Sibilia J et al (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide propective multicenter study. Arthritis Rheum 52(12):3792-3800
16. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F et al (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179(2):151-157
17. Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB (2006) Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 25:866-872
18. Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N (2002) Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 29:282-287
19. Guillevin L (2009) Vasculopathy and pulmonary arterial hypertension. Rheumatology 48(Suppl 3):iii54-iii57
20. Wigley FM (1996) Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension. Curr Opin Rheumatol 8:561-568
21. Cefle A, Inanc M, Sayarlioglu M, Kamali S, Gul A, Ocal L, et al (2011) Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int 31(2):183-189
22. Kasparian A, Floros A, Gialafos E, Kanakis M, Tassiopoulos S, Kafasi N et al (2007) Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 16(7):505-508
23. Levien TL (2010) Advances in the treatment of Raynaud's phenomenon. Vasc Health Risk Manag 24(6):167-177
24. Haas C (2004) Pulmonary hypertension associated with systemic lupus erythematosus. Bull Acad Natl Med 188(6):985-997
25. Assous N, Allanore Y, Batteux F, Meune C, Toulon P, Weill B et al (2005) Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury. Clin Exp Rheumatol 23(2):199-204
26. Asherson RA, Cervera R (2007) Pulmonary hypertension, antiphospholipid antibodies and syndromes. Clin Rev Allergy Immunol 32(2):153-158
27. Grunig E, Ehlken N, Ch Nagel (2008) Anticoagulation in pulmonary arterial hypertension. Hamostaseologie 8(4):225-230
28. Nishimaki T, Aotsuka S, Kondo H, Yamamoto K, Takasaki Y, Sumiya M et al (1999) Immunological analysis of pulmonary hypertension in connective tissue disease. J Rheumatol 26(11):2357-2362
29. Gussin HA, Ignat GP, Varga J, Teodorescu M (2001) Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 44(2):376-383
30. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T et al (2004) American College of Chest Physicians. Prognosis of pulmonary arterial hypertension: ACCP evidencebased clinical practice guidelines. Chest 126(1 Suppl):78S-92S
31. Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM (1997) Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 36:239-243
32. Vachiery JL, Brimioulle S, Crasset V, Naeije R (1998) Falsepositive diagnosis of pulmonary hypertension by Doppler echocardiography. Eur Respir J 12:1476-1478